seed
Stage
1
Investors
About
Cartagenia develops software solutions for the analysis of genetic data to support diagnostic processes and enable personalized medicine.
Explore Cartagenia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.